Intravenous Nimodipine West European Stroke Trial "INWEST"

Terminated

Phase N/A Results

Summary of Purpose

To evaluate whether intravenously administered nimodipine for a period of 5 days, followed by oral nimodipine until day 21, improves neurological and functional outcome in acute ischemic stroke patients.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 16 July 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Bayer AG

Trial Design

Randomized, double-blind, placebo-controlled trial of 295 patients at 34 centers.

Contacts

Not available